Neil Littman

Experience

Founder

Virtual venture capital firm and curated marketplace helping angel investors identify, fund, and support promising life science and health-tech startups. Interested in the... more

California Institute for Regenerative Medicine

Director, Business Development

$3 billion AUM targeting regenerative medicine. Head of BD for a portfolio of >70 RegenMed programs and manage operations for investments totaling >$250 million.

Deal Labs

Director, Life Sciences

Start-up FinTech company w/ a focus on equity-based crowdfunding. Successfully raised $3.9 million for Cosano Medical and $360k for Nueon (Dx for cardiovascular disease).

Burrill & Company

Senior Associate

Life sciences dedicated venture fund w/ >$1 billion AUM and boutique I-bank

UCSF Entrepreneurship Center

Advisor

Thomas Weisel Partners

Financial Analyst

Underwriter on $60 million IPO of Vanda Pharmaceuticals (most successful IPO of 2006 class). Placement agent on $30 million registered direct offering to deCODE Genetics.

Deutsche Bank

Financial Analyst

Advisor to Cephalon on $160 million acquisition of Salmedix (Phase 2 asset for CLL). Placement agent for Cephalon on $920 million senior subordinated convertible notes offering.... more

Founder

Bioverge

Employee

Deutsche Bank, Thomas Weisel Partners, Burrill & Company, Deal Labs, California Institute for Regenerative Medicine

Advisor

UCSF Entrepreneurship Center

Education

About

Skills

Business Development Financial Analysis Biotechnology Regenerative medicine Stem Cell Biology Molecular Biology Mergers & Acquisitions Financial Modelling & Valuation Strategic Planning Technology Transfer Corporate Finance Corporate Development

Locations

San Francisco Silicon Valley New York Boston Baltimore

Neil Littman

Founder @Bioverge. VP of BD @Notable. Investing in the future: bio + tech @Notable @Ligandal @Echo Laboratories @CrowdMed @Blue Mesa Health (acq. by Virgin Pulse)